BlackRock Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $471K | Buy |
54,522
+17,688
| +48% | +$153K | ﹤0.01% | 2188 |
|
|
2016
Q3 | $233K | Sell |
36,834
-59,055
| -62% | -$374K | ﹤0.01% | 2542 |
|
|
2016
Q2 | $405K | Buy |
95,889
+1,941
| +2% | +$8.2K | ﹤0.01% | 2193 |
|
|
2016
Q1 | $410K | Buy |
93,948
+2,686
| +3% | +$11.7K | ﹤0.01% | 2147 |
|
|
2015
Q4 | $559K | Sell |
91,262
-17,777
| -16% | -$109K | ﹤0.01% | 1992 |
|
|
2015
Q3 | $624K | Sell |
109,039
-2,981
| -3% | -$17.1K | ﹤0.01% | 2001 |
|
|
2015
Q2 | $836K | Buy |
112,020
+67,054
| +149% | +$500K | ﹤0.01% | 1756 |
|
|
2015
Q1 | $269K | Buy |
44,966
+6,102
| +16% | +$36.5K | ﹤0.01% | 2480 |
|
|
2014
Q4 | $294K | Sell |
38,864
-3,381
| -8% | -$25.6K | ﹤0.01% | 2342 |
|
|
2014
Q3 | $219K | Sell |
42,245
-1,983
| -4% | -$10.3K | ﹤0.01% | 2522 |
|
|
2014
Q2 | $191K | Sell |
44,228
-6,711
| -13% | -$29K | ﹤0.01% | 2627 |
|
|
2014
Q1 | $208K | Buy |
50,939
+10,089
| +25% | +$41.2K | ﹤0.01% | 2593 |
|
|
2013
Q4 | $218K | Buy |
40,850
+3,505
| +9% | +$18.7K | ﹤0.01% | 2586 |
|
|
2013
Q3 | $187K | Buy |
37,345
+6,660
| +22% | +$33.3K | ﹤0.01% | 2587 |
|
|
2013
Q2 | $137K | Buy |
+30,685
| New | +$137K | ﹤0.01% | 2688 |
|